DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 205 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,624,958 | -25.8% | 165,643 | -19.5% | 0.00% | – |
Q4 2022 | $2,189,957 | -0.5% | 205,823 | -2.3% | 0.00% | – |
Q3 2022 | $2,200,000 | -38.9% | 210,737 | -26.3% | 0.00% | -100.0% |
Q2 2022 | $3,599,000 | +16.1% | 285,806 | +0.0% | 0.00% | 0.0% |
Q1 2022 | $3,099,000 | -31.1% | 285,801 | -10.7% | 0.00% | 0.0% |
Q4 2021 | $4,501,000 | +317.5% | 319,898 | +489.3% | 0.00% | – |
Q1 2018 | $1,078,000 | +6.2% | 54,289 | 0.0% | 0.00% | – |
Q4 2017 | $1,015,000 | -21.1% | 54,289 | -28.8% | 0.00% | – |
Q4 2014 | $1,286,000 | – | 76,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |